The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice

Takayasu Ideta(Gifu University), Masahito Shimizu(Gifu University)
International Journal of Molecular Sciences
December 8, 2015
Cited by 57


Related Papers